Author:
Custro Nicola,Ganci A.,Scafidi V.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference17 articles.
1. Boddenberg B., Voth E., Scicha H. Immunogen hyper-thireose nach Radiojod-ablation einer fokalen autonomie. Nucl. Med. 1993, 32: 18–22.
2. Chiovato L., Santini F., Vitti P., Bendinelli G., Pinchera A. Appearance of thyroid stimulating antibody and Graves’ disease after radioiodine therapy for toxic nodular goiter. Clin. Endocrinol. 1994, 40: 803–806.
3. Nygaard B., Faber J., Veje A., Hegedus L., Hansen J.M. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131-I therapy. Thyroid 1999, 9: 477–481.
4. Nygaard B., Knudsen J.H., Hagedus L., Scient A.V., Hansen J.E. Thyrotropin receptor antibodies and Graves’ disease, a side-effect of 131-I treatment in patients with nontoxic goiter. J. Clin. Endocrinol. Metab. 1997, 82: 2926–2930.
5. Smyth P.P.A., Neylan D., McMullan N.M., Smith D.F., McKenna T.J. Sequential presentation of a case of hyperthyroidism with autonomously functioning nodules and Graves’ disease in the presence of IgG thyroid stimulators. Acta Endocrinol. (Copenhagen) 1988, 118: 474–478.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献